Pfizer’s $4.9bn Metsera bet: can amylin finally tame GLP-1’s ‘GI tax’?
Pfizer has rejoined the weight-loss race with a $4.9bn move
More Than a Shot: Sanofi’s Vicebio Deal Shows the Power of Platform Biotech
In the high-stakes world of biotechnology, big pharma acquisitions often
Roche’s Bold Foray into Obesity Treatment: A $5.3 Billion Bet on Petrelintide
In a strategic move poised to reshape the landscape of
Merck KGaA in Talks to Acquire U.S. Biotech Firm SpringWorks, Valued at $4 Billion
Merck KGaA, Darmstadt, Germany, is reportedly in advanced negotiations to
Pharma Giant Eli Lilly to Buy Biotech Firm Morphic for $3.2 Billion
Eli Lilly and Company, a global leader in pharmaceutical development,
Orna Therapeutics Acquires ReNAgade Therapeutics to Enhance RNA Medicine Development
Orna Therapeutics, a Massachusetts-based biotech firm specializing in circular RNA
Vector Laboratories and Absolute Biotech Announce Merger to Strengthen Life Sciences Capabilities
Vector Laboratories and Absolute Biotech have announced a merger, aiming
AstraZeneca Completes Equity Investment in Cellectis to Enhance Gene Therapy Development
AstraZeneca has completed its planned equity investment in Cellectis, a
MOST POPULAR
